Study Summary
This trial reports that a less invasive but effective treatment, stereotactic body radiation therapy (SBRT), is well-tolerated for early stage lung cancer in medically inoperable patients.
- Lung Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 5 years
Trial Safety
Trial Design
1 Treatment Group
EBUS-TBNA
1 of 1
Experimental Treatment
150 Total Participants · 1 Treatment Group
Primary Treatment: EBUS-TBNA · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any available slots for patients to join the clinical trial?
"Affirmative. The clinicaltrial.gov database reveals that this trial, which was initially launched on February 1st 2021, is currently recruiting. Approximately 150 participants need to be sourced from a single site." - Anonymous Online Contributor
What is the aggregate participation rate in this trial?
"Affirmative. Clinicaltrials.gov contains details confirming that this clinical trial is actively recruiting participants, beginning on February 1st 2013 and last updated on October 31st 2022. This experiment aims to enrol 150 volunteers from a single site." - Anonymous Online Contributor